TARGETING THE SUBTYPE OF METASTATIC PROSTATE CANCER DEFICIENT IN DNA REPAIR CAPACITY

$119,079FY2018Department of the ArmyDOD

Seattle Institute For Biomedical And Clinical Research

Investigators